P

Poltreg SA
WSE:PTG

Watchlist Manager
Poltreg SA
WSE:PTG
Watchlist
Price: 26.1 PLN -0.76% Market Closed
Market Cap: zł121.6m

Net Margin

-9 751.2%
Current
Declining
by 6 390.4%
vs 3-y average of -3 360.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-9 751.2%
=
Net Income
zł-24.4m
/
Revenue
zł250k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-9 751.2%
=
Net Income
zł-24.4m
/
Revenue
zł250k

Peer Comparison

Country Company Market Cap Net
Margin
PL
Poltreg SA
WSE:PTG
121.7m PLN
Loading...
US
GE Vernova LLC
NYSE:GEV
198.8B USD
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
104.1B ZAR
Loading...
US
Schlumberger NV
NYSE:SLB
74.2B USD
Loading...
US
Baker Hughes Co
NASDAQ:BKR
56.6B USD
Loading...
CH
Galderma Group AG
SIX:GALD
34.4B CHF
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
36.5B USD
Loading...
US
Symbotic Inc
NASDAQ:SYM
31.9B USD
Loading...
ZA
Vukile Property Fund Ltd
JSE:VKE
30.8B ZAR
Loading...

Market Distribution

Lower than 96% of companies in Poland
Percentile
4rd
Based on 886 companies
4rd percentile
-9 751.2%
Low
-9 940 700% — -3.7%
Typical Range
-3.7% — 9.1%
High
9.1% — 196 605.3%
Distribution Statistics
Poland
Min -9 940 700%
30th Percentile -3.7%
Median 2.9%
70th Percentile 9.1%
Max 196 605.3%

Poltreg SA
Glance View

Market Cap
121.6m PLN
Industry
N/A

PolTREG SA develops and commercializes patented TREG methods. The company is headquartered in Gdansk, Woj. Pomorskie and currently employs 11 full-time employees. The company went IPO on 2021-11-23. The firm conducts research in the field of autoimmunological diseases. The firm works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The firm works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The firm is developing its own research center, which is intended as a basic location for conducting future research activities.

PTG Intrinsic Value
1.11 PLN
Overvaluation 96%
Intrinsic Value
Price
P
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-9 751.2%
=
Net Income
zł-24.4m
/
Revenue
zł250k
What is Poltreg SA's current Net Margin?

The current Net Margin for Poltreg SA is -9 751.2%, which is below its 3-year median of -3 360.8%.

How has Net Margin changed over time?

Over the last 3 years, Poltreg SA’s Net Margin has decreased from -315.4% to -9 751.2%. During this period, it reached a low of -9 751.2% on Jun 30, 2025 and a high of -155.9% on Mar 31, 2023.

Back to Top